Lanean...
Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies
It has been nearly two decades since RNA-interference (RNAi) was first reported. While there are no approved clinical uses, several promising phase II and III clinical trials suggest the great promise of RNAi therapeutics. One challenge for RNAi therapies is the controlled localization and sustained...
Gorde:
| Argitaratua izan da: | Adv Healthc Mater |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5226889/ https://ncbi.nlm.nih.gov/pubmed/27976524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.201601041 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|